Prevalence of antimicrobial-resistant organisms in residential aged care facilities

Medical Journal of Australia

Volumn 195, Issue 9, 2011, Pages 530-533

  Stuart, Rhonda L ^a   Kotsanas, Despina ^a   Webb, Brooke ^a   Vandergraaf, Susan ^a   Gillespie, Elizabeth E ^a   Hogg, Geoffrey G ^b   Korman, Tony M ^a  

^a MONASH MEDICAL CENTRE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE CTX M; CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; NORFLOXACIN; SULFAMETHOXAZOLE; TRIMETHOPRIM; VANCOMYCIN;

ADULT; AGE; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL TRANSMISSION; CLOSTRIDIUM DIFFICILE; EMERGENCY CARE; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; FECES ANALYSIS; FEMALE; GENOTYPE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR TYPING; MULTIDRUG RESISTANCE; PREVALENCE; QUESTIONNAIRE; RESIDENTIAL HOME; RISK FACTOR; SEX RATIO; URINARY CATHETER; VANCOMYCIN RESISTANT ENTEROCOCCUS; AUSTRALIA; CLINICAL TRIAL; CLOSTRIDIUM INFECTION; DRUG EFFECT; ENTEROCOCCUS; ESCHERICHIA COLI INFECTION; GRAM POSITIVE INFECTION; HETEROZYGOTE; HOME FOR THE AGED; MIDDLE AGED; MULTICENTER STUDY; NURSING HOME;

ADULT; AGED; AGED, 80 AND OVER; BETA-LACTAM RESISTANCE; CARRIER STATE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROCOCCUS; ESCHERICHIA COLI INFECTIONS; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HOMES FOR THE AGED; HUMANS; MALE; MIDDLE AGED; NURSING HOMES; PREVALENCE; RISK FACTORS; VANCOMYCIN RESISTANCE; VICTORIA;

EID: 84855167744     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/mja11.10724     Document Type: Article

References (37)

1. Padiglione AA, Wolfe R, Grabsch EA, et al. Risk factors for new detection of vancomycin-resistant enterococci in acute-care hospitals that employ strict infection control procedures. Antimicrob Agents Chemother 2003; 47: 2492-2498.
2. Bartlett JG. Narrative review: the new epidemic of Clostridium difficile-associated enteric disease. Ann Intern Med 2006; 145: 758-764.
3. McDonald LC, Owings M, Jernigan DB. Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003. Emerg Infect Dis 2006; 12: 409-415.
4. Riley TV, Thean S, Hool G, Golledge CL. First Australian isolation of epidemic Clostridium difficile PCR ribotype 027 Med J Aust 2009; 190: 706-708.
5. Richards M, Knox J, Elliott B, et al. Severe infection with Clostridium difficile PCR ribotype 027 acquired in Melbourne, Australia. Med J Aust 2011; 194: 369-371.
6. Schwaber MJ, Navon-Venezia S, Kaye KS, et al. Clinical and economic impact of bacteremia with extended-spectrum-beta-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother 2006; 50: 1257-1262.
7. Pop-Vicas A, Mitchell SL, Kandel R, et al. Multidrug-resistant gram-negative bacteria in a long-term care facility: prevalence and risk factors J Am Geriatr Soc 2008; 56: 1276-1280.
8. Muder RR, Brennen C, Drenning SD, et al. Multiply antibiotic-resistant gram-negative bacilli in a long-term-care facility: a case-control study of patient risk factors and prior antibiotic use. Infect Control Hosp Epidemiol 1997; 18: 809-813.
9. Wiener J, Quinn JP, Bradford PA, et al. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes JAMA 1999; 281: 517-523.
10. Pitout JD, Laupland KB. Extended-spectrum p-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 2008; 8: 159-166.
11. Bradford PA. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001; 14: 933-951.
12. Kennedy K, Collignon P. Colonisation with Escherichia coli resistant to "critically important" antibiotics: a high risk for international travellers. Eur J Clin Microbiol Infect Dis 2010; 29: 1501-1506.
13. Ortega M, Marco F, Soriano A, et al. Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antimicrobial-resistant strain and their impact on the outcome. J Antimicrob Chemother 2009; 63: 568-574.
14. Friedmann R, Raveh D, Zartzer E, et al. Prospective evaluation of colonization with extended-spectrum p-lactamase (ESBL)-producing Enterobacteriaceae among patients at hospital admission and of subsequent colonization with ESBL-producing Enterobacteriaceae among patients during hospitalization. Infect Control Hosp Epidemiol 2009; 30: 534-542.
15. Ben-Ami R, Schwaber MJ, Navon-Venezia S, et al. Influx of extended-spectrum beta-lactamase-producing Enterobacteriaceae into the hospital. Clin Infect Dis 2006; 42: 925-934.
16. Livermore DM, Paterson DL. Pocket guide to extended-spectrum p-lactamases in resistance. New Delhi: Springer (India) Private Limited, 2006.
17. McGeer A, Campbell B, Emori TG, et al. Definitions of infection for surveillance in long-term care facilities. Am J Infect Control 1991; 19: 1-7
18. Teixeira LM, Carvalho M, Facklam RR. Enterococcus. In: Murray PR, Baron EJ, Jorgensen JH, et al, editors. Manual of clinical microbiology. Washington, DC: American Society for Microbiology, 2007: 430-442.
19. Grabsch EA, Ghaly-Derias S, Gao W, Howden BP. Comparative study of selective chromogenic (chromID VRE) and bile esculin agars for isolation and identification of vanB-containing vancomycin-resistant enterococci from feces and rectal swabs J Clin Microbiol 2008; 46: 4034-4036.
20. Novak-Weekley SM, Marlowe EM, Miller JM, et al. Clostridium difficile testing in the clinical laboratory by use of multiple testing algorithms. J Clin Microbiol 2010; 48: 889-893.
21. Réglier-Poupet H, Naas T, Carrer A, et al. Performance of chromID ESBL, a chromogenic medium for detection of Enterobacteriaceae producing extended-spectrum beta-lactamases. J Med Microbiol 2008; 57: 310-315.
22. Midolo PD, Matthews D, Fernandez C, Kerr TG. Detection of extended spectrum p-lactamases in the routine clinical microbiology laboratory. Pathology 2002; 34: 362-364.
23. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33: 2233-2239.
24. Lindstedt B, Brandal LT, Aas L, et al. Study of polymorphic variable-number of tandem repeats loci in the ECOR collection and in a set of pathogenic Escherichia coli and Shigella isolates for use in a genotyping assay. J Microbiol Methods 2007; 69: 197-205.
25. Johnson PD, Ballard SA, Grabsch EA, et al. A sustained hospital outbreak of vancomycin-resistant Enterococcus faecium bacteremia due to emergence of vanB E faecium sequence type 203. J Infect Dis 2010; 202: 1278-1286.
26. Padiglione AA, Grabsch E, Wolfe R, et al. The prevalence of fecal colonization with VRE among residents of long-term-care facilities in Melbourne, Australia. Infect Control Hosp Epidemiol 2001; 22: 576-578.
27. Xie C, Taylor DM, Howden BP, Charles PG. Comparison of the bacterial isolates and antibiotic resistance patterns of elderly nursing home and general community patients. Intern Med J 2011 Jan 17 [Epub ahead of print].
28. Drees M, Snydman DR, Schmid CH, et al. Prior environmental contamination increases the risk of acquisition of vancomycin-resistant enterococci. Clin Infect Dis 2008; 46: 678-685.
29. Trick WE, Weinstein RA, DeMarais PL, et al. Colonization of skilled-care facility residents with antimicrobial-resistant pathogens J Am Geriatr Soc 2001; 49: 270-276.
30. Rooney PJ, O'Leary MC, Loughrey AC, et al. Nursing homes as a reservoir of extended-spectrum beta-lactamase (ESBL)-producing ciprofloxacin-resistant Escherichia coli. J Antimicrob Chemother 2009; 64: 635-641.
31. Cukier L, Lutzler P, Bizien A, Avril JL [Investigation of an epidemic of an extended spectrum beta-lactamase producing Escherichia coli in a geriatrics department] [French]. Pathol Biol (Paris) 1999; 47: 440-444.
32. Ma L, Matsuo H, Ishii Y, Yamaguchi K. Characterization of cefotaxime-resistant Escherichia coli isolates from a nosocomial outbreak at three geriatric hospitals J Infect Chemother 2002; 8: 155-162.
33. Zong Z, Partridge SR, Thomas L, Iredell JR. Dominance of blaCTX-M within an Australian extended-spectrum beta-lactamase gene pool. Antimicrob Agents Chemother 2008; 52: 4198-4202.
34. Mendelson G, Hait V, Ben-Israel J, et al. Prevalence and risk factors of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in an Israeli long-term care facility. Eur J Clin Microbiol Infect Dis 2005; 24: 17-22.
35. Donskey CJ. The role of the intestinal tract as a reservoir and source for transmission of nosocomial pathogens. Clin Infect Dis 2004; 39: 219-226.
36. Pacio GA, Visintainer P, Maguire G, et al. Natural history of colonization with vancomycin-res is tant enterococci, methicillin-resistant Staphylococcus aureus, and resistant gram-negative bacilli among long-term-care facility residents. Infect Control Hosp Epidemiol 2003; 24: 246-250.
37. Arpin C, Dubois V, Maugein J, et al. Clinical and molecular analysis of extended-spectrum p-lactamase-producing enterobacteria in the community setting. J Clin Microbiol 2005; 43: 5048-5054.